Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 37, Issue 4, 1998, Pages 377-385

  Kumra, Sanjiv ^a   Jacobsen, Leslie K ^a   Lenane, Marge ^a   Karp, Barbara I ^b   Frazier, Jean A ^c   Smith, Amy K ^a   Bedwell, Jeffrey ^a   Lee, Paul ^a   Malanga, C J ^a   Hamburger, Susan ^a   Rapoport, Judith L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Childhood onset schizophrenia; Clozapine; Olanzapine

Indexed keywords

CLOZAPINE; HALOPERIDOL; OLANZAPINE; RISPERIDONE; THIORIDAZINE;

ADOLESCENT; ARTICLE; CHILD; CHILD PSYCHIATRY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER TOXICITY; MALE; NEUROTOXICITY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; TACHYCARDIA;

EID: 0031977902     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199804000-00015     Document Type: Article

References (45)

1. Alaghband-Rad J, McKenna K, Gordon CT et al. (1995), Childhood-onset schizophrenia: the severity of premorbid course. J Am Acad Child Adolesc Pychiatry 34:1273-1283
2. American Psychiatric Association (1987), Diagnostic and Statistical Manual of Mental Disorders, 3rd edition-revised (DSM-III-R). Washington, DC: American Psychiatric Association
3. Andreasen NC (1983), Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa
4. Andreasen NC (1984), Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa
5. Asarnow R, Brown W, Strandburg R (1995), Children with a schizophrenic disorder: neurobehavioral studies. Eur Arch Psychiatry Clin Neurosci 245:70-79
6. Beasley C, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S (Olanzapine HGAD Study Group) (1996), Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 14:111-123
7. Bertolino A, Kumra S, Callicott J et al. (1997), Proton magnetic resonance spectroscopic imaging in childhood onset schizophrenia. Biol Psychiatry 41:595
8. Birmaher B, Baker R, Kapur S, Quintana H, Ganguli R (1991), Clozapine for the treatment of adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 31:160-164
9. Borrison RL (1997), Recent advances in the pharmacotherapy of schizophrenia. Harv Rev Psychiatry 4:255-271
10. Bunney W, Hamburg D (1963), Methods for reliable longitudinal observation of behavior. Arch Gen Psychiatry 9:114-128
11. Bymaster FP, Calligaro DO, Falcone JF et al. (1996), Radioceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 114:87-96
12. Campbell M, Palig M (1985), Subjective Treatment Emergent Symptoms Scale (STESS). Psychopharmacol Bull 21:1063-1082
13. Conley R, Tamminga C, Beasley C, Maryland Study Group (1997), Olanzapine vs chlorpromazine in treatment-refractory schizophrenia. Biol Psychiatry 41:73S
14. Frazier J, Giedd J, Hamburger S et al. (1996), Brain anatomic MRI in childhood-onset schizophrenia. Arch Gen Psychiatry 53:617-624
15. Frazier JA, Gordon CT, McKenna K, Lenane MC, Jih D, Rapoport JL (1994), An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 33:658-663
16. Gordon CT, Frazier JA, McKenna K et al. (1994), Childhood-onset schizophrenia: an NIMH study in progress. Schizophr Bull 20:697-712
17. Guy W (1976), CGI Clinical Global Impressions: ECDEU Assessment Manual, revised edition. Rockville, MD: US Department of Health, Education and Welfare, pp 218-222
18. Jacobsen LK, Hong W, Hommer D et al. (1996), Smooth pursuit eye movements in childhood onset schizophrenia: comparison with ADHD and normal controls. Biol Psychiatry 40:1144-1154
19. Jacobsen LK, Rapoport JL (in press), Research update: childhood onset schizophrenia-implications of clinical and neurobiological research. J Child Psychol Psychiatry
20. Jacobsen LK, Walker M, Edwards J, Chappell P, Woolston J (1994), Clozapine in the treatment of a young adolescent with schizophrenia. J Am Acad Child Adolesc Psychiatry 33:645-650
21. Kane J, Honigfeld G, Singer J, Meltzer H, Clozaril Collaborative Study Group (1988), Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796
22. Kumra S, Frazier J, Jacobsen LK et al. (1996), Childhood-onset schizophrenia: a double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 53:1090-1097
23. Lieberman JA, Safferman AZ, Pollack S et al. (1994), Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry 151:1744-1752
24. McGlashan TH, Johannessen JO (1996), Early detection and intervention with schizophrenia: rationale. Schizophr Bull 22:201-222
25. McKenna K, Gordon C, Lenane M, Kaysen D, Fahey K, Rapoport J (1994), Looking for childhood-onset schizophrenia: the first 71 cases screened. J Am Acad Child Adolesc Psychiatry 33:636-644
26. Meltzer H (1992), Treatment of the neuroleptic nonresponsive schizophrenic patient. Schizophr Bull 18:515-542
27. Meltzer HY, Bastani B, Kwon KY, Ramirez LF, Burnett S, Sharpe J (1989), A prospective study of clozapine in treatment-resistant schizophrenic patients, I: preliminary report. Psychopharmacology (Berl) 99:S68-S72
28. Mozes T, Toren P, Chernauzan N et al. (1994), Case study: clozapine treatment in very early onset schizophrenia. J Am Acad Child Adolesc Psychiatry 33:65-70
29. Orvaschel H, Tabrizi M, Chambers W (1980), Schedule for Affective Disorders and Schizophrenia for School-Age Children-Epidemiologic Version (Kiddie-SADS-E), 3rd ed. Fort Lauderdale, FL: Nova University
30. Overall J, Gorham D (1962), The Brief Psychiatric Rating Scale. Psychiatry Res 10:799-812
31. Owen RR, Beake BJ, Marby D, Dessan EC, Cole JO (1989), Response to clozapine in chronic psychotic patients. Psychopharmacol Bull 25:253-256
32. Pickar D, Owen RR, Litman RE, Konicki E, Gutierrez R, Rapaport MH (1992), Clinical and biologic response to clozapine in patients with schizophrenia: crossover comparison with fluphenazine. Arch Gen Psychiatry 49:345-353
33. Pool D, Bloom W, Mielke D, Roniger J, Gallant D (1976), A controlled evaluation of Loxitane in seventy-five adolescent schizophrenic patients. Curr Ther Res 19:99-104
34. Rapoport J, Connors C, Reatig N (1985), Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21:1077-1079
35. Rapoport JL, Giedd J, Kumra S et al. (1997), Childhood onset schizophrenia: progressive ventricular change during adolescence. Arch Gen Psychiatry 54:897-903
36. Reich W, Welner Z (1988), DICA-RC (DSM-III-R Version), revised version, V-R. St Louis: Washington University
37. Remschmidt H, Schulz E, Martin M (1994), An open trial of clozapine in thirty-six adolescents with schizophrenia. J Child Adolesc Psychopharmacol 4:31-41
38. Schmidt M, Trott G, Blanz B, Nissen G (1989), Clozapine medication in adolescents. In: Psychiatry: A World Perspective, Proceedings of the VIII World Congress of Psychiatry, Vol 1. Athens, pp 1100-1104
39. Shaffer D, Gould M, Brasic J et al. (1983), A children's global assessment scale (CGAS). Arch Gen Psychiatry 40:1228-1231
40. Siefen G, Remschmidt H (1986), Treatment results with clozapine in schizophrenic adolescents. Z Kinder Jugenpsychiatr 14(3):245-257
41. Simpson G, Angus JSW (1970), A rating scale for extrapyramidal side effects. Acts Psychiatr Scand 212:9-11
42. Spencer EK, Kafantaris V, Padron-Gayol MV, Rosenberg CR, Campbell M (1992), Haloperidol in schizophrenic children: early findings from a study in progress. Psychopharmacol Bull 28:183-186
43. Szymanski S, Lieberman J, Pollack S et al. (1996), Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics. Biol Psychiatry 39:249-254
44. Towbin K, Dykens E, Pugliese R (1994), Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome. J Am Acad Child Adolesc Psychiatry 33:651-657
45. Zahn TP, Jacobsen LK, Gordon C, McKenna K, Frazier J, Rapoport JL (1997), Autonomic nervous system markers of psychopathology in childhood-onset schizophrenia. Arch Gen Psychiatry 54:904-912